These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The treatment of multiple sclerosis with beta-interferon. Poser CM Neuroepidemiology; 2008; 31(3):157-8. PubMed ID: 18716413 [No Abstract] [Full Text] [Related]
5. [The role of interferon beta in the treatment of multiple sclerosis]. Seeldrayers P Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902 [TBL] [Abstract][Full Text] [Related]
6. Pearls and pitfalls of interferon beta treatment for multiple sclerosis. Corona T; León C; Ruiz JL Neurologia; 1999 Nov; 14(9):467-8. PubMed ID: 10613023 [No Abstract] [Full Text] [Related]
7. Should neutralizing antibodies be monitored during interferon-beta treatment for multiple sclerosis? Oger J; Gibbs E Nat Clin Pract Neurol; 2006 Feb; 2(2):76-7. PubMed ID: 16932528 [No Abstract] [Full Text] [Related]
8. [Treatment of relapsing-remitting multiple sclerosis with interferon beta type 1-b]. Bencsik K; Rajda C; Klivényi P; Járdánházy T; Török M; Vécsei L Orv Hetil; 1999 Apr; 140(14):763-6. PubMed ID: 10224846 [TBL] [Abstract][Full Text] [Related]
9. [Advances in the therapy of multiple sclerosis with interferon beta-1a]. Nervenarzt; 1997 Oct; 68(10 Suppl):1-8. PubMed ID: 9375645 [No Abstract] [Full Text] [Related]
10. [High doses of interferon in the treatment of multiple sclerosis]. Muñoz D Rev Neurol; 2001 May 1-15; 32(9):899. PubMed ID: 11424041 [No Abstract] [Full Text] [Related]
11. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis]. Sommer S; Sablon JC; Zaoui M; Rozot P; Hosni A J Fr Ophtalmol; 2001 May; 24(5):509-12. PubMed ID: 11397988 [TBL] [Abstract][Full Text] [Related]
12. [Interferon in multiple sclerosis. The earlier, the better?]. MMW Fortschr Med; 2001 May; 143 Suppl 2():94. PubMed ID: 11434275 [No Abstract] [Full Text] [Related]
13. Targets for the therapeutic action of interferon-beta in multiple sclerosis. Hartung HP; Kieseier BC Ann Neurol; 1996 Dec; 40(6):825-6. PubMed ID: 9007085 [No Abstract] [Full Text] [Related]
14. The use of interferon beta at the time of initial diagnosis of multiple sclerosis. Pender MP J Clin Neurosci; 2001 Jul; 8(4):381-2. PubMed ID: 11437589 [No Abstract] [Full Text] [Related]
15. [Interferon beta-1b in multiple sclerosis. Basic therapy in intermittent and secondary progressive course]. Nervenarzt; 1999 Nov; 70(11 Suppl Basisthera):1-4. PubMed ID: 10603601 [No Abstract] [Full Text] [Related]
16. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? Hodgkinson SJ J Clin Neurosci; 2001 Jul; 8(4):378-9. PubMed ID: 11437587 [No Abstract] [Full Text] [Related]
17. The use of interferon beta in relapsing-remitting multiple sclerosis. Etheridge LJ; Beverley DW; Ferrie C; McManus E Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086 [TBL] [Abstract][Full Text] [Related]
19. Should all patients with an initial diagnosis of multiple sclerosis be treated with beta interferon? The case against. Macdonell R J Clin Neurosci; 2001 Jul; 8(4):379-81. PubMed ID: 11437588 [No Abstract] [Full Text] [Related]
20. Use of interferon-beta in the treatment of multiple sclerosis. Derwenskus J; Lublin FD Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838 [No Abstract] [Full Text] [Related] [Next] [New Search]